非知名Biotech,曲线上岸

瞪羚社
14 Nov 2024

上方“瞪羚社”即刻关注并加入社群聚焦高成长公司,100000+投资菁英共同关注关于药企借壳上市的案例并不罕见,前些日子的亿腾与嘉和的并购就已经在行业内被热议。在目前上市困难的情况下,走“借壳”曲线上市的路线,是一个非常具有性价比的选择。那么,买美股的壳子直接上纳斯达克呢?昨日,睿跃生物(Cullgen)发布公告,其与纳斯达克一家名为Pulmatrix(股票代码:PULM)的biotech达成合并...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10